Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sinocare Inc.
Janux reported early clinical trial data for its lead asset JANX007 that may show differentiated efficacy in the crowded PSMA space and for an EGFR agent with lung and kidney tumor shrinkage.
Turnstone’s initial public offering comes just one week after Apogee and Sagimet launched US IPOs. Also, Westlake Village BioPartners raised $450m for its third venture capital fund and argenx grossed $1.27bn in a post-Phase III follow-on offering.
Investment bank analysts, VC funds and biopharma companies all sought to calm investors’ nerves as a go-to financial institution for tech and biotech collapsed.
The deal bolsters Sanofi’s immuno-oncology pipeline and marks its sixth acquisition this year.
- Monitoring Equipment & Devices
In Vitro Diagnostics
- Glucose Testing
- Other Names / Subsidiaries
- Freedom Meditech, Inc.
- Home Diagnostics Inc.
- Nipro Diagnostics, Inc.
- Trividia Health, Inc.
- PTS Diagnostics
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.